Adocia Stock OTC Markets
Stocks
ADOIF
FR0011184241
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 80.92M 93.55M 75.57M 69.33M 130M 8.9B 132M 887M 348M 4.46B 351M 344M 14.75B | P/E 2026 * |
-755x | P/E 2027 * | 5.98x |
|---|---|---|---|---|---|
| Enterprise Value | 51.08M 59.05M 47.7M 43.76M 82.31M 5.62B 83.61M 560M 220M 2.82B 222M 217M 9.31B | EV / Sales 2026 * |
20.3x | EV / Sales 2027 * | 3.14x |
| Free-Float |
95.03% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -5.93% |
| Manager | Title | Age | Since |
|---|---|---|---|
Olivier Soula
CEO | Chief Executive Officer | 55 | 11/05/2023 |
| Director of Finance/CFO | - | 23/09/2024 | |
Martin Gaudier
CTO | Chief Tech/Sci/R&D Officer | - | 01/12/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Olivier Soula
BRD | Director/Board Member | 55 | 19/04/2013 |
Gérard Soula
CHM | Chairman | 80 | 24/02/2012 |
| Director/Board Member | 58 | 18/06/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.93% | -12.50% | - | - | 93.55M | |
| +8.49% | +20.55% | +70.77% | +110.32% | 68.12B | |
| +1.25% | +2.44% | +34.27% | +70.43% | 55.18B | |
| -1.09% | +32.96% | +19.67% | +494.56% | 28.63B | |
| +10.83% | +18.38% | +56.20% | +6.03% | 23.99B | |
| +2.72% | +3.41% | -16.11% | -7.96% | 23.53B | |
| +6.50% | +7.56% | +44.65% | -21.73% | 18.45B | |
| +6.20% | +11.51% | +33.87% | +693.38% | 16.44B | |
| -3.88% | +16.98% | +199.30% | +359.77% | 15.83B | |
| +3.58% | +1.96% | +43.35% | +163.76% | 13.4B | |
| Average | +2.87% | +11.68% | +54.00% | +207.62% | 29.28B | |
| Weighted average by Cap. | +4.35% | +13.10% | +50.69% | +168.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.52M 2.92M 2.35M 2.16M 4.06M 277M 4.13M 27.63M 10.84M 139M 10.95M 10.71M 460M | 35.4M 40.92M 33.06M 30.33M 57.04M 3.89B 57.95M 388M 152M 1.95B 154M 150M 6.45B |
| Net income | -4.32M -4.99M -4.03M -3.7M -6.96M -475M -7.07M -47.3M -18.57M -238M -18.74M -18.33M -787M | -44.33M -51.25M -41.4M -37.97M -71.42M -4.88B -72.56M -486M -191M -2.44B -192M -188M -8.08B |
| Net Debt | -29.84M -34.5M -27.87M -25.57M -48.09M -3.28B -48.85M -327M -128M -1.65B -130M -127M -5.44B | 30.18M 34.89M 28.18M 25.85M 48.62M 3.32B 49.39M 331M 130M 1.66B 131M 128M 5.5B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
